Building a Future Free From Vaccine-preventable Diseases
Sabin strengthens communities by advancing global immunization and developing innovative vaccines.
Sabin supports the professionals most responsible for ensuring all communities receive the maximum benefit vaccines can deliver. We work with partners to better understand and address vaccine acceptance, demand and delivery barriers; bolster professional collaboration; foster action to develop new and universal vaccines; and better apply epidemiology to maximize vaccine rollout effectiveness.
We Generate Evidence
We provide data that policy makers need to drive informed immunization decisions.
We Explore Vaccine Acceptance
We work in LMIC communities to understand the factors and cultural contexts that lie at the heart of vaccine acceptance and demand. We also connect journalists with health workers, as they are trusted voices of health information
We Strengthen Immunization Capacity
We empower immunization professionals to improve vaccine access and health care systems from the ground up.
We Power Vaccine R&D
We focus on developing vaccines that disproportionately affect people living in LMICs.
Our mission is to make vaccines more accessible, enable innovation and expand immunization across the globe.
1,0001,000 people in 50 countries engaged in virtual dialogues on tackling vaccine misinformation.
2,100+The Boost Community supports more than 2,100 immunization professionals around the world.
4,000The Applied Epidemiology program gathered 4,000 blood samples to study low-cost surveillance tools for typhoid.
5,000+More than 5,000 volunteers, including 600 pediatrics, have received our Ebola Sudan and Marburg vaccines and no severe adverse events have been reported.
Disease Focus Areas
We help advance vaccines for diseases that take a devastating toll on lives and economies. And we work to ensure vaccines reach the most vulnerable communities.
Gold Medal and Rising Star Nominations Open
Sabin Statement on the End of the Uganda Ebola Outbreak
We make vaccines more accessible, enable innovation and expand immunization across the globe.